Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
25.72
+2.12 (8.98%)
At close: Aug 13, 2025, 4:00 PM
25.10
-0.62 (-2.41%)
Pre-market: Aug 14, 2025, 9:09 AM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
$1,228,426
Profits / Employee
-$2,004,443
Market Cap
489.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NKTR News
- 5 days ago - Nektar Therapeutics (NKTR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Nektar Therapeutics Reports Second Quarter 2025 Financial Results - PRNewsWire
- 13 days ago - Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets - PRNewsWire
- 16 days ago - Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata - PRNewsWire
- 6 weeks ago - Nektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 6 weeks ago - Nektar Therapeutics Announces Pricing of $100 Million Public Offering - PRNewsWire
- 6 weeks ago - Nektar Therapeutics Announces Proposed Public Offering - PRNewsWire
- 6 weeks ago - Nektar Therapeutics Scores Big Phase 2b Win With Rezpeg - Seeking Alpha